Recent Updates
Recently added Catalysts
IMRX Positive Sentiment

Loretta Sullivan, MD, MPH

Tuesday, February 10, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Loretta Sullivan, MD, MPH, is a seasoned leader in global health with a rich background in the biopharmaceutical industry. She has worked with major companies like Genentech and Lilly, and has extensive experience as an epidemiologist with organizations such as the CDC and WHO. Dr. Sullivan's education includes degrees from Dartmouth, UCLA, and the University of Colorado. She is also a veteran and resides in Denver with her family.
Price reaction · baseline $5.12 (2026-02-10T20:38:00.000Z) · hit during market hours · 2 other IMRX headline(s) in the window, move may be shared
day 0 close · peak
-2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Sullivan has extensive experience in global health.
  • She has held leadership roles in prominent biopharmaceutical companies.
  • Her diverse background includes work with major health organizations.
  • She is a veteran and multilingual, showcasing her commitment.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+41%
120-day peak, hindsight
Typical move
11.4%
average across 8 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 Monotherapy
Phase 1 · Advanced Solid Tumor

Full Press Release Details

Loretta Sullivan, MD, MPH, has dedicated her life to improving global health. Over the last decade, she has held clinical leadership roles within the biopharmaceutical industry, including Genentech/Roche, Lilly, Astellas, J&J, ALX Oncology and Clovis Oncology. Prior to joining industry, Dr. Sullivan worked as an epidemiologist with the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and various non-governmental organizations in over 30 countries. Dr. Sullivan earned her undergraduate degree from Dartmouth College, her MPH in epidemiology at UCLA and her medical degree at the University of Colorado with an internal medicine residency at UCLA and hematology/oncology fellowship at Stanford. She is a veteran, having served in the U.S. Public Health Service, and she is fluent in five languages. Loretta lives in Denver, Colorado, with her husband and three sons. In her spare time, she plays USTA tennis and loves to ski.

Frequently Asked Questions

What is Dr. Loretta Sullivan's professional background?

Dr. Sullivan has held leadership roles in biopharmaceutical companies and worked as an epidemiologist.

Where did Dr. Sullivan earn her medical degree?

She earned her medical degree from the University of Colorado.

What organizations has Dr. Sullivan worked with?

She has worked with the CDC, WHO, and various NGOs in over 30 countries.

What languages does Dr. Sullivan speak?

Dr. Sullivan is fluent in five languages.

ShareAdd on Google
Tags: IMRX Viatris Investor Conferences Healthcare Loretta Sullivan biopharmaceutical industry global health CDC WHO
Last updated: Feb 10, 2026

Biotech snapshot

Cash runway
$202M liquidity · $6M/mo burn
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 MonotherapyPhase 1
Advanced Solid Tumor →

Catalyst track record

+41%
best trade around IMRX's most recent catalyst

Peak hindsight return over a 120-day window, across 8 tracked FDA/PDUFA catalysts for IMRX.

See every catalyst's timing & PoA →